Drudy D - Search Results

1

PCR-ribotype distribution of Clostridium difficile in Irish pigs.

Stein K, Egan S, Lynch H, Harmanus C, Kyne L, Herra C, McDermott S, Kuijper E, Fitzpatrick F, FitzGerald S, Fenelon L, Drudy D. Stein K, et al. Among authors: drudy d. Anaerobe. 2017 Dec;48:237-241. doi: 10.1016/j.anaerobe.2017.10.004. Epub 2017 Oct 9. Anaerobe. 2017. PMID: 29024758

2

Flow cytometric analysis of Clostridium difficile adherence to human intestinal epithelial cells.

Drudy D, O'Donoghue DP, Baird A, Fenelon L, O'Farrelly C. Drudy D, et al. J Med Microbiol. 2001 Jun;50(6):526-534. doi: 10.1099/0022-1317-50-6-526. J Med Microbiol. 2001. PMID: 11393290

3

Human antibody response to surface layer proteins in Clostridium difficile infection.

Drudy D, Calabi E, Kyne L, Sougioultzis S, Kelly E, Fairweather N, Kelly CP. Drudy D, et al. FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):237-42. doi: 10.1016/j.femsim.2004.03.007. FEMS Immunol Med Microbiol. 2004. PMID: 15196573 Free article.

4

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.

Sougioultzis S, Kyne L, Drudy D, Keates S, Maroo S, Pothoulakis C, Giannasca PJ, Lee CK, Warny M, Monath TP, Kelly CP. Sougioultzis S, et al. Among authors: drudy d. Gastroenterology. 2005 Mar;128(3):764-70. doi: 10.1053/j.gastro.2004.11.004. Gastroenterology. 2005. PMID: 15765411 Clinical Trial.

5

Toxin A-negative, toxin B-positive Clostridium difficile.

Drudy D, Fanning S, Kyne L. Drudy D, et al. Int J Infect Dis. 2007 Jan;11(1):5-10. doi: 10.1016/j.ijid.2006.04.003. Epub 2006 Jul 20. Int J Infect Dis. 2007. PMID: 16857405 Free article. Review.

6

High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.

Drudy D, Quinn T, O'Mahony R, Kyne L, O'Gaora P, Fanning S. Drudy D, et al. J Antimicrob Chemother. 2006 Dec;58(6):1264-7. doi: 10.1093/jac/dkl398. Epub 2006 Oct 3. J Antimicrob Chemother. 2006. PMID: 17018563

7

Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland.

Drudy D, Harnedy N, Fanning S, O'Mahony R, Kyne L. Drudy D, et al. Clin Microbiol Infect. 2007 Mar;13(3):298-304. doi: 10.1111/j.1469-0691.2006.01634.x. Clin Microbiol Infect. 2007. PMID: 17391385 Free article.

8

gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.

Drudy D, Kyne L, O'Mahony R, Fanning S. Drudy D, et al. Emerg Infect Dis. 2007 Mar;13(3):504-5. doi: 10.3201/eid1303.060771. Emerg Infect Dis. 2007. PMID: 17552115 Free PMC article. No abstract available.

9

Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.

Drudy D, Harnedy N, Fanning S, Hannan M, Kyne L. Drudy D, et al. Infect Control Hosp Epidemiol. 2007 Aug;28(8):932-40. doi: 10.1086/519181. Epub 2007 Jun 29. Infect Control Hosp Epidemiol. 2007. PMID: 17620240

10

First isolation and report of clusters of Clostridium difficile PCR 027 cases in Ireland.

Long S, Fenelon L, Fitzgerald S, Nolan N, Burns K, Hannan M, Kyne L, Fanning S, Drudy D. Long S, et al. Among authors: drudy d. Euro Surveill. 2007 Apr 26;12(4):E070426.3. doi: 10.2807/esw.12.17.03183-en. Euro Surveill. 2007. PMID: 17868610 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page